Active tuberculosis in Africa is associated with reduced Th1 and increased Th2 activity in vivo
Christian Lienhardt(Institut de Recherche pour le Développement), Gianfranco Del Prete(University of Florence), Kebba Manneh, Roberto Manetti(University of Florence), Marisa Benagiano(University of Florence), Boubacar Bah(Laboratoire National de Santé), Mario Milco D’Elios(University of Florence), Amedeo Amedei(University of Florence), Per Gustafson(Lund University), Steve Bennett(London School of Hygiene & Tropical Medicine), Keith P. W. J. McAdam(London School of Hygiene & Tropical Medicine), Alimou Diallo(Laboratoire National de Santé), Oumou Younoussa Sow(Laboratoire National de Santé), Annalisa Azzurri(University of Florence), Jackson Sillah(MRC Unit the Gambia), Katherine Fielding
European Journal of Immunology
June 1, 2002
Cited by 230
Related Papers
Bulletin of the World Health Organization
|Bulletin of the World Health Organization|2001|7.2k
Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
|Clinical Infectious Diseases|2016|1.5k
Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial
|The Lancet|2001|528
Newborns Develop a Th1-Type Immune Response to <i>Mycobacterium bovis</i> Bacillus Calmette-Guerin Vaccination
|The Journal of Immunology|1999|405